[IF=20.722] Meng Lin. et al. CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy. Nano Today. 2022 Feb;42:101359 IF ; Mouse.
[IF=16.016] Jia-min Yan. et al. Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress. 2021 Nov 06 WB,IF ; Human.
[IF=15.304] Jinbo Li. et al. Autophagy inhibition recovers deficient ICD-based cancer immunotherapy. BIOMATERIALS. 2022 Aug;287:121651 IF ; Mouse.
[IF=15.304] Yao Lei. et al. Phytochemical natural killer cells reprogram tumor microenvironment for potent immunotherapy of solid tumors. BIOMATERIALS. 2022 Jun;:121635 IF ; Mouse.
[IF=14.593] Ya-nan Fu. et al. Spatiotemporally dynamic therapy with shape-adaptive drug-gel for the improvement of tissue regeneration with ordered structure. Bioact Mater. 2021 Jun;: IHC ; Rat.
[IF=14.588] Donglin Xia. et al. Au–Hemoglobin Loaded Platelet Alleviating Tumor Hypoxia and Enhancing the Radiotherapy Effect with Low-Dose X-ray. Acs Nano. 2020;14(11):15654–15668 IF ; Mouse.
[IF=11.467] Shuang Zhou. et al. Tumor microenvironment adrenergic nerves blockade liposomes for cancer therapy. J CONTROL RELEASE. 2022 Nov;351:656 IF ; Mouse.
[IF=10.723] Jie Zhou. et al. Hyaluronic acid-based dual network hydrogel with sustained release of platelet-rich plasma as a diabetic wound dressing. CARBOHYD POLYM. 2023 Aug;314:120924 IF ; Rat.
[IF=9.58] Youjin Hu. et al. Genetic landscape and autoimmunity of monocytes in developing Vogt–Koyanagi–Harada disease. P Natl Acad Sci Usa. 2020 Oct;117(41):25712-25721 IF ; Human.
[IF=7.901] Z Wang et al. Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB0,+ for efficient tumor therapy. J Control Release. 2019 Dec 28;316:22-33. ICF ; Rabbit.
[IF=7.032] Ruicheng Yang. et al. circ_2858 Helps Blood-Brain Barrier Disruption by Increasing VEGFA via Sponging miR-93-5p during Escherichia coli Meningitis. Mol Ther-Nucl Acids. 2020 Dec;22:708 IF ; Human.
[IF=6.633] Li-Ming Yu. et al. Icariin attenuates excessive alcohol consumption-induced susceptibility to atrial fibrillation through SIRT3 signaling. BBA-MOL BASIS DIS. 2022 Oct;1868:166483 IF ; Mouse.
[IF=6.304] Hongmei Liu. et al. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR. Cell Death Dis. 2020 Aug;11(8):1-15 IF ; Human.
[IF=5.5] Chen, Yejia. et al. Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis. THROMB J. 2022 Dec;20(1):1-14 IF ; Mouse.
[IF=5.5] Sun J et al. LncRNA Expression Profile of Human Thoracic Aortic Dissection by High-Throughput Sequencing.Cell Physiol Biochem. 2018;46(3):1027-1041. FCM ; Rabbit.
[IF=5.23] Ma, Jie, et al. "CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies." Scientific Reports 7 (2017). IF(IHC-F) ; Rabbit.
[IF=4.96] Nan Cheng. et al. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy. Biochem Pharmacol. 2021 Jan;183:114298 IF ; Mouse.
[IF=4.845] Zhenjie Wanget al. Single-ligand dual-targeting irinotecan liposomes: Control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicity. Int J Pharm
. 2020 Sep 25;587:119680. IF ; rabbit.
[IF=4.831] Haoqiang Zhang. et al. Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.. Aging-Us. 2021 Jan 15; 13(1): 525–536 IF ; Fish.
[IF=4.167] Cui Z et al. Cryptosporidium parvum gp40/15 Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Vaccine Target. Microorganisms. 2020 Mar 4;8(3). IF ; human.
[IF=4.047] Wang Luyang. et al. Enrichment and proteomic identification of Cryptosporidium parvum oocyst wall. PARASITE VECTOR. 2022 Dec;15(1):1-10 IF ; Cryptosporidium parvum.
[IF=4.014] Zhenlei Ping. et al. Effect of Angelica Sinensis extract on the angiogenesis of preovulatory follicles (F1-F3) in late-phase laying hens. POULTRY SCIENCE. 2022 Dec;:102415 IF ; Chicken.
[IF=4.011] Shiozawa M et al. Biological reaction control using topography regulation of nanostructured titanium. Sci Rep. 2020 Feb 12;10(1):2438. ICF ; Rabbit.
[IF=3.776] Ruidong Ge. et al. Quantitative proteomics reveals potential anti-inflammatory protein targets of radial extracorporeal shock wave therapy in TNF-α-induced model of acute inflammation in primary human tenocytes. HELIYON. 2022 Dec;8:e12008 IF ; Human.
[IF=3.647] Zijian Geng. et al. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells. Life Sci. 2021 Aug;278:119547 IF ; Bovine.
[IF=3.575] Yuxin Zheng. et al. Development and characterization of a novel mouse anti-canine oncostatin M receptor beta monoclonal antibody. BIOCHEM BIOPH RES CO. 2022 Jul;614:114 IF ; Human.
[IF=3.264] Yang, Rui-Cheng. et al. Transcriptional landscape of human neuroblastoma cells in response to SARS-CoV-2. BMC NEUROSCI. 2022 Dec;23(1):1-12 IF ; Human.
[IF=3.264] Zhang Haoyun. et al. Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model. BMC NEUROSCI. 2022 Dec;23(1):1-14 IF ; Mouse.
[IF=3.118] Huang L et al. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS. (2018) Int Immunopharmacol. 65:96-107. IF ; Rabbit.
[IF=3.061] Zhang D et al. Crocin alleviates lipopolysaccharide-induced acute respiratory distress syndrome by protecting against glycocalyx damage and suppressing inflammatory signaling pathways. . Inflamm Res. 2020 Mar;69(3):267-278. ICF ; Rabbit.
+86 571 56623320
